Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 20 January 2022
      It’s time to Power Up Health Systems
The COVID-19 crisis has put the resilience and agility of European health systems to the test in an unprecedented way. As we are continuing the fight against COVID-19 together we also need to reflect on what this crisis has taught us so far about the state of European health systems, and what could be done better or differently in the future.

EFPIA believes that five key dimensions should be the guide when reforming and investing in our health systems: People, Outcomes, Workforce, Efficiency and Resilience. 


 
 
      News
 
  20 January 2022 EFPIA statement on the EMA Accelerating Clinical Trials in the EU (ACT EU) initiative

The aim is to further develop the EU as a focal point for clinical research, further promote the development of high...

Read more →
 
 
 
      19 Conversations | EFPIA's Podcast Series
Listen to more episodes on efpia.eu
 
 
  30 April 2021 Podcast: What value do Public Private Partnerships bring for society?

Welcome to 19 conversations

Read more →
 
 
 
      Events
 
 
24 JAN 2022
  Supporting Pharma Innovation in Europe Virtual event

Presented by the FT, in partnership with EFPIA.

Learn more →
 
 
 
26 JAN 2022
  Introducing the Innovative Health Initiative: Europe’s new partnership for health... Virtual event

Registration is now open!

Learn more →
 
 
 
10 FEB 2022
  10th ACCELERATE Paediatric Oncology Conference Virtual event

Last days to register!

Learn more →
 
 
 
14 FEB 2022
  Implementing "Good Lay Summary Practice" Virtual event

Registrations are now open for the upcoming Multi-stakeholder Workshop on Implementing "Good Lay Summary Practice".

Learn more →
 
 
      We published
EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report 06 January 2022 (News & Events)
Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy...
Read more →
 
      What we are reading
A timely reality check on silent pandemic of antimicrobial resistance 20 January 2022  (IFPMA) Read more →
Biopharmaceutical industry: A buoyant economy is cause for cautious optimism 17 January 2022  (The Irish Times) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe